Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma
Silvia Regina Graziani Carolina Graziani Vital; Aleksandra Tiemi Morikawa; Brigitte M. Van Eyll; Hézio Jadir Fernandes Júnior; Roberto Kalil Filho; Raul Cavalcante Maranhão
Medical Oncology Totowa v. 34, p. 1-7 art. 151, 2017Totowa 2017
Disponible en FM - Fac. Medicina (BCSEP 208 2017 )(Obténgalo)